A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

Trial Identifier: D4191R00099
Sponsor: AstraZeneca
Collaborator:
Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)
Start Date: August 2025
Primary Completion Date: February 2026
Study Completion Date: February 2026
Condition: Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aichi, Japan
Japan Chiba, Japan
Japan Ehime, Japan
Japan Fukuoka, Japan
Japan Fukushima, Japan
Japan Hokkaido, Japan
Japan Hyogo, Japan
Japan Ishikawa, Japan
Japan Kagawa, Japan
Japan Kanagawa, Japan
Japan Kochi, Japan
Japan Kyoto, Japan
Japan Miyagi, Japan
Japan Nara, Japan
Japan Oita, Japan
Japan Okayama, Japan
Japan Osaka, Japan
Japan Saitama, Japan
Japan Shizuoka, Japan
Japan Tochigi, Japan
Japan Tokyo, Japan
Japan Wakayama, Japan